Revenue for the quarter was 10.3% higher y-o-y at $7.95 million, due to higher revenue from the group’s Obstetrics & Gynaecology (O&G) and Cancer-related segments as well as a contribution of $0.1 million from the new Paediatrics segment.
SINGAPORE (Feb 20): Singapore O&G (SOG) on Feb 14 announced that its 4Q17 earnings increased 165.8% to $2.02 million from $0.76 million in 4Q16.
This brought FY17 earnings to $8.51 million, 3.4% lower than $8.80 million last year.
